ENTO has been in the news 900% more than usual
Sep 14, 2024, 4:32 AM
40.90%
What does ENTO do
First Wave Biopharma, headquartered in Boca Raton, Florida, develops nonsystemic therapies for gastrointestinal diseases and went public in October 2016. Its key programs include latiglutenase, capeserod, and adrulipase.
ENTO has been in the news recently: Mereo BioPharma's CEO, Dr. Denise Scots-Knight, is scheduled to speak at the 2024 Cantor Global Healthcare Conference on September 18, 2024. Zenas BioPharma successfully priced its IPO at $17.00 per share, raising around $225 million by offering 13,235,294 shares.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.